Personalized Treatment in Myelofibrosis: Applying the Data to Address Barriers and Improve Care
Download these slides from a live symposium featuring guidance from a clinical pharmacist and a specialty pharmacist on best practices for individualized management of patients with myelofibrosis, including evidence-based treatment options and the role of pharmacists in providing patient support, symptom and toxicity management, and monitoring.
Assistant Professor Department of Pharmacy Practice Loma Linda University, School of Pharmacy Clinical Pharmacy Specialist Specialty Pharmacy Services Loma Linda University Medical Center Loma Linda, California
Victoria R. Nachar, PharmD, BCOP
Clinical Pharmacist Specialist Hematology University of Michigan Rogel Cancer Center Ann Arbor, MI
Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC
This educational activity is supported by an educational grant from GSK .
Clinical Care Options, LLC
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.